Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
10.22
+0.15 (1.49%)
At close: Oct 6, 2025, 4:00 PM EDT
9.88
-0.34 (-3.33%)
After-hours: Oct 6, 2025, 4:24 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $62.87 million as of October 6, 2025. Its market cap has increased by 38.91% in one year.
Market Cap
62.87M
Enterprise Value
-53.38M
1-Year Change
38.91%
Ranking
Category
Stock Price
$10.22
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $62.87M, a decrease of -88.64%. That is a compound annual growth rate of -35.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 61.94M | -58.11% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
| Oct 16, 2020 | 553.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |